We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
-7.23%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$5.58B
AUM Growth
-$2.21B
Cap. Flow
-$1.68B
Cap. Flow %
-30.12%
Top 10 Hldgs %
58.92%
Holding
80
New
11
Increased
25
Reduced
9
Closed
15

Top Buys

Rank Stock Value
1
FTAI icon
FTAI Aviation
FTAI
+$313M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$153M
3
VST icon
Vistra
VST
+$141M
4
NFE icon
New Fortress Energy
NFE
+$115M
5
MCY icon
Mercury Insurance
MCY
+$98.2M

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$251M
2
UAL icon
United Airlines
UAL
+$96.7M
3
FLR icon
Fluor
FLR
+$65.3M
4
DAL icon
Delta Air Lines
DAL
+$49M
5
PARA
Paramount Global Class B
PARA
+$48.5M

Sector Composition

Rank Sector Weight
1 Healthcare 37.06%
2 Utilities 27.45%
3 Energy 10.46%
4 Financials 7.97%
5 Technology 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SEG
51
Seaport Entertainment Group
SEG
$373M
$12.3M 0.22%
573,408
– –
MGTX icon
52
MeiraGTx Holdings
MGTX
$1.2B
$12M 0.22%
+1,776,321
New +$11.9M
ZVRA icon
53
Zevra Therapeutics
ZVRA
$679M
$9.12M 0.16%
1,217,734
+601,611
+98% +$4.78M
CXW icon
54
CoreCivic
CXW
$3.32B
$7.99M 0.14%
+393,889
New +$7.93M
OABI icon
55
OmniAb
OABI
$497M
$6.84M 0.12%
2,850,588
– –
ABUS icon
56
Arbutus Biopharma
ABUS
$907M
$5.87M 0.11%
1,681,090
– –
CHRS icon
57
Coherus Oncology
CHRS
$181M
$4.24M 0.08%
5,258,754
– –
PRLB icon
58
Protolabs
PRLB
$2.17B
$4.06M 0.07%
+115,952
New +$4.57M
ANIP icon
59
ANI Pharmaceuticals
ANIP
$1.73B
$3.79M 0.07%
56,671
– –
MYPS icon
60
PLAYSTUDIOS Inc
MYPS
$72.1M
$3.44M 0.06%
2,711,190
– –
EDSA icon
61
Edesa Biotech
EDSA
$51.1M
$1.68M 0.03%
+687,500
New +$1.48M
OVID icon
62
Ovid Therapeutics
OVID
$489M
$1.66M 0.03%
5,315,969
– –
HOWL icon
63
Werewolf Therapeutics
HOWL
$18.6M
$1.3M 0.02%
1,333,893
– –
TXMD icon
64
TherapeuticsMD
TXMD
$24.1M
$1.1M 0.02%
1,192,191
– –
ARDX icon
65
Ardelyx
ARDX
$1.03B
– –
-1,706,485
Closed -$8.65M
DAL icon
66
Delta Air Lines
DAL
$59.1B
– –
-810,536
Closed -$49M
FLR icon
67
Fluor
FLR
$6.96B
– –
-1,325,000
Closed -$65.3M
FOXF icon
68
Fox Factory Holding Corp
FOXF
$913M
– –
-331,900
Closed -$10M
GDRX icon
69
GoodRx Holdings
GDRX
$1.22B
– –
-5,804,628
Closed -$27M
IBIT icon
70
iShares Bitcoin Trust
IBIT
$47.2B
– –
-553,353
Closed -$29.4M
IWM icon
71
PUT
iShares Russell 2000 ETF
IWM
$82.2B
– –
-5,070,000
Closed -$1.12B
PARA
72
DELISTED
Paramount Global Class B
PARA
– –
-4,632,083
Closed -$48.5M
PFSI icon
73
PennyMac Financial
PFSI
$4B
– –
-200,000
Closed -$20.4M
PUMP icon
74
ProPetro Holding
PUMP
$1.42B
– –
-2,158,725
Closed -$20.1M
RSKD icon
75
Riskified
RSKD
$846M
– –
-1,066,025
Closed -$5.04M
1 2
3
4

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
LAMI
Longview Asset Management (Illinois) Chicago, Illinois $9.56B AUM 25.94% 1-Year Est. Return
CCMT
CMT Capital Markets Trading Frankfurt, Germany $9.56B AUM 21.2% 1-Year Est. Return

Rubric Capital Management (New York)'s Q1 2025 Portfolio in Review

As of Q1 2025, Rubric Capital Management (New York) held 80 positions worth $5.58B, down 28% from $7.79B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Rubric Capital Management (New York) withdrew a net $1.68B in Q1 2025, closing 15 positions and reducing 9 holdings. Its most notable exit was Viatris, an estimated $251M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 28% a quarter earlier, followed by Utilities and Energy.

Against the trend, Rubric Capital Management (New York) opened a new position in FTAI Aviation worth $294M.

  • Rubric Capital Management (New York)'s largest Q1 2025 buy was FTAI Aviation: 2,645,000 shares worth $294M.
  • Rubric Capital Management (New York) added most to Teva Pharmaceuticals in Q1 2025, an estimated $153M increase.
  • Rubric Capital Management (New York)'s biggest Q1 2025 reduction was Roivant Sciences, cutting an estimated $24.1M.
  • Rubric Capital Management (New York) fully exited Viatris in Q1 2025, selling an estimated $251M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 59% of its $5.58B portfolio in Q1 2025.
  • Rubric Capital Management (New York) opened 11 new positions and closed 15 in Q1 2025.
  • Rubric Capital Management (New York)'s portfolio value fell 28% quarter-over-quarter to $5.58B.

Based on Rubric Capital Management (New York)'s 13F filing for Q1 2025, filed 14 May 2025.